作为无并发症严重急性营养不良 (AMOUR) 的辅助治疗方法的阿兹罗米辛:双面罩随机对照试验的研究协议
Mamadou Bountogo1,2, Alphonse Zakane1, Thierry A Ouedraogo1
1Centre de Recherche en Sante de Nouna, Nouna, Burkina Faso.
BMJ open
|July 1, 2025
概括
这项研究比较了阿齐思罗密,阿莫西西林和安慰剂,用于治疗儿童严重急性营养不良 (SAM). 该AMOUR试验调查哪种抗生素,如果有的话,可以改善SAM的幼儿的营养恢复和生存.
科学领域:
- 儿童传染病 儿童传染病
- 营养科学 营养科学
- 临床试验方法论 临床试验方法论
背景情况:
- 氨基西林是严重急性营养不良 (SAM) 的标准,但有效性和坚持是令人担忧的.
- 单剂量抗生素阿齐思罗米已经显示出对儿童的死亡率有好处.
- 该AMOUR试验评估了阿齐思罗密辛,阿莫西西林和安慰剂,用于无并发症的SAM门诊治疗.
研究的目的:
- 为了比较阿齐思罗密,阿莫西西林和安慰剂在治疗6-59个月龄的儿童无并发性严重急性营养不良 (SAM) 的疗效.
- 评估这些治疗对营养恢复,死亡率和复发率的影响.
- 评估与不同抗生素剂量方案相关的坚持因素.
主要方法:
- 这是一项双面罩,随机对照试验,涉及3000名6-59个月龄的儿童,患有无并发性SAM.
- 参与者按1:1:1随机分配,接受阿齐思罗密辛 (单剂量),阿莫西西林 (7天疗程) 或安慰剂7天.
- 主要结局是8周体重增加;次要结局包括死亡率和评估到12个月的复发.
主要成果:
- 主要终点:8周后体重增加 (g/kg/天).
- 二级终点:在8周,3,6,9和12个月评估的死亡率和复发率.
- 试验的注册:NCT06010719. 试验的注册:NCT06010719. 试验的注册:NCT06010719. 试验的注册:NCT06010719. 试验的注册:NCT06010719.
结论:
- 这项AMOUR试验将提供关于治疗严重急性营养不良的最佳抗生素策略的关键数据.
- 研究结果将为儿童营养不良的治疗指南提供信息,有可能提高康复率并降低死亡率.
- 结果将向卫生当局,利益相关者和科学界传播.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
559
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
559
Tonsillitis II: Management
179
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
179
Antimicrobial Effectiveness
175
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
175
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Fungal Phylum Microsporidia
127
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
127


